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Abstract
Background: Cardiometabolic (CM) risk affects approximately 25% of adults globally, and is diagnosed by meeting
3 out of 5 of the following CM risk factors: elevated blood pressure, high triglycerides, elevated blood sugar, low
high-density lipoprotein (HDL) level, and abdominal obesity. Adults with CM risk are approximately 22% more likely
to have higher mortality rates, and alcohol consumption may be associated with higher CM risk. While previous
studies have investigated this potential connection, the majority of them did not include African-origin adults.
Therefore, the study aimed to explore the association between alcohol intake and CM risk in 5 African-origin
cohorts, spanning the epidemiologic transition in Ghana, South Africa, Jamaica, Seychelles and the United States of
America.
Methods: Measurements included clinical measures for CM risk and self-reported alcohol consumption. Each
participant was categorized into one of three drinking categories: non-drinker, light drinker (1–3 drinks daily for
men and 1–2 drinks daily for women) and heavy drinker (4 or more drinks every day for men and 3 or more drinks
per day for women). Using non-drinker status as the reference, the association between alcohol consumption status
and prevalence of each of the five CM risk factors and overall elevated CM risk (having 3 out of 5 risk factors) was
explored, adjusting for site, age and sex. Associations were explored using logistic regression and significance was
determined using odds ratios (OR) and 95% confidence intervals.
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Results: Neither light nor heavy drinking was associated with increased odds for having higher CM risk compared
to nondrinkers (OR = 1.05, p = 0.792 and OR = 1.11, p = 0.489, respectively). However, light drinking was associated
with lower odds for having low high density lipoproteins (HDL) cholesterol (OR = 0.69, p = 0.002) and increased risk
for high triglycerides (OR = 1.48, p = 0.030). Heavy drinking was associated with elevated blood pressure (OR = 1.59,
p = 0.002), high triglycerides (OR = 1.73, p = 0.006) and decreased risk of low HDL-cholesterol (OR = 0.621, p <
0.0005). Finally, country-specific analyses indicated that the relationship between heavy drinking and elevated CM
risk varied widely across sites.
Conclusion: While several CM risk factors were associated with alcohol consumption, the associations were
inconsistent and varied widely across five international cohorts of African-origin. Future studies should focus on
understanding the individual site-related effects.
Keywords: African-origin populations, Cardiometabolic risk, Alcohol consumption, And Epidemiologic transition
Background
Cardiometabolic (CM) risk affects approximately 25%
of adults globally [1, 2]. The National Cholesterol
Education Program Expert Panel on Detection, Evalu-
ation and Treatment of High Blood Cholesterol in
Adults defines diagnosis as having any three of the
following five CM risk factors: elevated blood pres-
sure, high triglycerides (TG), elevated blood sugar,
low high-density lipoprotein (HDL) level and abdom-
inal obesity [3–5]. It is estimated that mortality rates
are approximately 22% higher for adults with high
CM risk compared to healthy adults [6]. While sev-
eral non-modifiable risk factors, including age and sex
have been determined to increase CM risk; the con-
tribution of alcohol consumption remains inconsistent
[7–10]. For example, many studies have demonstrated
that the amount of alcohol intake is associated with
individual CM risk factors; including hypertension,
hypertriglyceridemia and hyperglycemia [7–9, 11, 12].
The level of alcohol consumption may show either in-
creased or decreased risk for the individual CM fac-
tors, [13–17]. Despite these independent associations,
data are lacking showing a causal link between alco-
hol consumption and overall CM risk. Given the
international prevalence of alcohol consumption, with
some countries reporting 80% of the population
drinking regularly, and the global burden of high CM
risk, this potential association warrants additional
examination [1, 2, 18–20].
Recently, a meta-analysis from the Global Burden of
Disease Study group examined 694 studies from 195
countries between 1990 and 2016, and found that al-
cohol consumption significantly increased CM risk
[10]. This contradicts previous studies, which found
that low levels of alcohol consumption may be pro-
tective against CM risk [21, 22]. For example, Frei-
berg et al. [22], reported that adults who regularly
drink small amounts of alcohol have 40% lower odds
for increased CM risk than adults who do not con-
sume alcohol. However, this effect was less significant
in African American participants than in white partic-
ipants. The contradictory findings between these two
studies suggests that any proposed associations have
not yet been confirmed.
Previous studies have shown genetic/phenotypic rela-
tionships between country of origin and CM health. Fac-
tors such as abdominal obesity, HDL-cholesterol and
other measures of CM health vary greatly due to differ-
ences in dietary and behavioral behaviors among coun-
tries [23, 24]. For example, a study that examined CM
risk in 195 countries showed that the prevalence of high
CM risk is higher in developing urban communities than
in rural or fully developed areas, suggesting an epidemi-
ologic effect on CM risk [23]. This may be as a result, in
part, due to a higher caloric intake and other behavioral
factors associated with urban populations as well as a
higher prevalence of obesity in the latter than the
former. A study examining rural and urban populations
from 200 countries found obesity to be associated dir-
ectly and fairly strongly with higher HDL-cholesterol,
triglycerides and blood sugar levels [25].
Some studies have examined CM risk in African-
origin populations living in Africa. However, to our
knowledge, no previous studies have examined the re-
lationship between alcohol consumption and CM risk
have included African-origin participants living in Af-
rica. Previous studies have already shown that differ-
ent populations are not similarly affected by the
separate factors, and that each population may re-
spond to alcohol consumption differently [13–15, 26].
Therefore, the aim of this investigation was to exam-
ine the association between alcohol consumption and
elevated CM risk in adults of African-origin using
data from the Modeling the Epidemiologic Transition
study (METS) [13, 14].
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Methods
METS is a prospective cohort study examining physical
activity and weight change in 5 African-origin cohorts
from Ghana, Jamaica, South Africa, Seychelles, and the
United States of America (USA) (N = 500 at each site).
METS was initiated in 2009. In total, 2506 participants
of African origin, aged 25–45 years were recruited. Ap-
proximately 50% of participants were women (N =
1339), and all participants self-identified as African-ori-
gin. Sites were categorized using the 2010 United Na-
tions’ Human Development Index (HDI) [15]. In 2010,
Ghana was ranked as low HDI (0.554), South Africa was
ranked as moderate (0.645), Seychelles and Jamaica were
ranked as high (0.747 and 0.712, respectively), and the
USA was ranked as very high (0.914). Data for the
current study were collected during the baseline clinic
visit, between the months of January 2009 and Decem-
ber 2011. The protocol for METS was approved by the
Institutional Review Board of Loyola University Chicago,
IL, USA (LU#200038); the Committee on Human Re-
search Publication and Ethics of Kwame Nkrumah Uni-
versity of Science and Technology, Kumasi, Ghana; the
Research Ethics Committee of the University of Cape
Town, South Africa; the Board for Ethics and Clinical
Research of the University of Lausanne, Switzerland; the
Research and Ethics Committee, Ministry of Health and
Social Development, Seychelles Public Health Depart-
ment, Republic of Seychelles, and the Ethics Committee
of the University of the West Indies, Kingston, Jamaica.
A written informed consent was obtained from all par-
ticipants before enrollment.
Study inclusion criteria included participants who self-
identified as African-origin and considered themselves
healthy. Participants with obvious infectious disease,
HIV positive individuals, women who were either lactat-
ing or pregnant, and participants unable to engage in
normal physical activity were not eligible for the study
due to the impact these conditions had on CM risk.
METS participants presented annually for a health
check, which included CM risk measurements, and self-
reported alcohol consumption. Two alcohol consump-
tion metrics were used to estimate drinking behavior:
the number of drinks per day and the frequency of
drinking. The clinical measurements were used to esti-
mate the prevalence of CM risk at each of the five sites.
Clinical measurements
All measurements were collected at outpatient research
clinics in the respective communities. Weight (kg) and
height (m) were collected while participants wore light
clothing and no shoes, using identical procedures and
equipment models across all five sites. This information
was used to calculate body mass index (BMI) (kg/m2).
BMI was used both continuously and categorically as
“not overweight” (BMI < 25 kg/m2) and “overweight/
obese (BMI ≥ 25 kg/m2). Waist circumference was also
collected using tape measures and recorded in both cen-
timeters and inches.
Blood pressure
Blood pressure (BP) measurements were performed by
trained personnel using an automatic digital monitor
(Omron model HEM-747Ic). Measurements were taken
with the antecubital fossa at heart level. BP was mea-
sured twice during the research visit with at least an
hour in between measurements. BP was measured in
triplicate each time, thus resulting in a total of six BP
measurements. BP was coded to be a dichotomous vari-
able based upon whether the participant was hyperten-
sive. In concordance with the American Heart
Association’s definition, elevated blood pressure was
identified by systolic blood pressure ≥ 130 mmHg, dia-
stolic blood pressure ≥ 90 mmHg or if the participant
was being treated for high blood pressure [26].
Biochemical measures
Blood glucose levels (mg/dL), cholesterol (mg/dL) and
triglyceride levels (mg/L) were obtained during the clinic
examination. Participants were asked to fast 10–12 h
prior to examination, during which fasting blood glucose
was measured and blood samples were drawn by
venipuncture using standard procedure. Fasting capillary
glucose concentrations were determined using finger
stick (Accu-check Aviva, Roche). Blood samples were
briefly processed, and plasma or serum separated within
2 h of collection. Afterwards, all samples were stored in
the laboratory at − 80 °C. Elevated blood glucose was de-
fined as ≥100 mg/dL or receiving treatment for type 2
diabetes, while elevated high triglyceride levels were de-
fined as ≥ 150 mg/dL or receiving treatment [3, 4]. Low
HDL cholesterol was defined as < 40mg/dL in men
and < 50 mg/dL in women or receiving treatment [3, 4].
Physical activity
All participants wore an accelerometer (Phillips Respiro-
nics, Bend, OR, USA), and instructed to wear it continu-
ously over their right hip. They were advised to only
remove it before bathing, showering, or swimming as
the device was not waterproof. The monitor measures
and records vertical accelerations to represent the inten-
sity of each movement. The intensity and duration of
physical activity was summarized in one minute epochs
over the course of seven days. Light, moderate and vig-
orous intensity activity were defined as < 1535 counts
per minute (cpm), 1535–3959 cpm and ≥ 3960 cpm, re-
spectively [27]. Physical activity was measured as mi-
nutes performed per day.
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Questionnaires
All questionnaires were administered by trained
personnel, as previously described [14]. The question-
naires inquired on each participant’s health information
with a focus on cardiovascular disease and type 2 dia-
betes. Data collected included dietary habits, medication
use, physical activity behavior and age of diagnosis for
relevant illnesses. The study also collected data on
household characteristics, participant occupation, educa-
tion, parental education, household assets and amenities.
Questions were based on the Core Welfare Indicators
Questionnaire from the World Bank [28].
Drinking status
The main exposure for the current study was alcoholic
intake, and participants were asked about their alcohol
consumption during the staff-administered interviews,
and the responses were used to determine patterns of al-
cohol consumption. The Alcohol Use Disorder Identifi-
cation Test was used to determine daily alcohol
consumption, which includes questions such as: “In the
past 12 months, how often have you drink (in days)? Per
Week, Per Month, Per Year?”, “On those days that you
drank, how many drinks did you have?”, and “On special
occasions, how many drinks do you have?” Participants
were categorized into 3 alcohol consumption groups,
using the guidelines provided by the National Institute
of Alcohol Abuse and Alcoholism (NIAAA) [29]. These
categories were non-drinkers (who indicated no alcohol
consumption), light drinker (who consumed 1–3 drinks
daily for men and 1–2 drinks daily for women) and
heavy drinker (who had 4 or more drinks every day for
men and 3 or more drinks per day for women).
Cardiometabolic risk
The main goal of the study was to measure elevated CM
risk. Participants were classified with high CM risk, if
they met any three of the following five CM criteria
established by the Adult Treatment Panel III [3, 4].
These included abdominal obesity (waist circumfer-
ence > 102 cm in males and > 88 cm in females); elevated
BP (≥130/80 mmHg), or receiving treatment for hyper-
tension; high TG (≥150 mg/dL); low HDL (HDL choles-
terol < 40mg/dL in males and < 50 mg/dL in females);
and elevated blood glucose (fasting plasma glucose ≥100
mg/dL).
Statistical analyses
Participant demographic and clinical data were summa-
rized using mean ± standard deviation, both individually
and overall. Categorical variables were displayed using N
and frequency. The relationship between alcohol con-
sumption (no alcohol, light drinking or heavy drinking)
and CM risk was explored using logistic regression, and
final results were determined using odds ratio (OR) and
95% confidence intervals (CI). Both daily consumption
and drinking frequency were used for these compari-
sons. Abstaining from alcohol consumption was used as
the reference category to which light and heavy drinkers
were compared. All models were adjusted for age, sex,
smoking status (smoker or non-smoker), self-reported
physical activity and site (dummy variables). Statistical
analyses were performed using Stata (version 12, Manu-
facturer, College Station, TX, USA) (year 2011). An




The descriptive characteristics of the five cohorts are
presented in Tables 1 and 2, by site and sex. For men,
the mean age ranged from 33.7 ± 5.8 years in South Af-
rica to 36.4 ± 5.1 years in the Seychelles (Table 1). For
women, the mean age ranged from 33.1 ± 6.0 years in
South Africa, to 35.8 ± 5.6 years in the Seychelles
(Table 2). Overall, participants from Ghana had the low-
est BMI and the subjects from the USA had the highest
BMI (Tables 1 and 2).
Drinking patterns
Tables 3 and 4, and Supplementary Figs. 1 and 2 present
the self-report drinking patterns for both men and
women, respectively, stratified by site, among partici-
pants who indicated that they consumed alcohol. Across
the five sites, about 19.4% of men qualified as abstainers,
while 36.3% were heavy drinkers. Ghanaian men re-
ported the lowest rates of drinking (42.5%), indicating
they do not drink regularly. While only 9.4% of men
from the USA did not drinking regularly. The highest
rates of light drinking were observed among Jamaican
men (67.1%), while the greatest rates were observed
among South African men (19.5%). Seychellois men had
the highest rates of heavy drinking (60.4%), while Ghan-
aian men reported the lowest rates of heavy drinking
(8.7%). Overall, women were less likely to drink, with
46.0% of them reporting irregular drinking habit. Fur-
thermore, 31.8% of women across all sites reported con-
suming 1–3 drinks daily on average, and 22.2% drank
more than three alcoholic beverages each day. Ghanaian
women had the lowest rates of drinking, with 77.5% in-
dicating irregular drinking, while women from the
Seychelles reported the highest rates of drinking, and
only 14.8% indicated not drinking regularly. It was ob-
served that women from the USA had the highest rates
of light drinking (55.3%), while South Africans reported
the lowest rates of light drinking among men (4.9%).
Seychellois women had the highest rates of heavy
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drinking (45.9%), while Ghanaian women showed the
lowest rates of heavy drinking (4.1%).
Cardiometabolic risk
The prevalence of CM risk is presented in Tables 5 and
6, and Supplementary Figs. 3 and 4, men, women, re-
spectively. Overall, USA men had the highest prevalence
of high CM risk (22.0%). However, Seychellois men had
the highest number of participants with elevated
blood glucose level (29.6%) (Supplementary Fig. 3).
South African men had the greatest number of partici-
pants with high blood pressure (47.9%). Hypertriglyc-
eridemia was observed more in Jamaican men (38.6%)
and Ghanaian men had the highest number of partici-
pants with low HDL (44.4%). Abdominal obesity was ob-
served among more men from the USA (35.0%).
More USA women (27.2%) had high CM risk (elevated
blood pressure: 34.6%, hypertriglyceridemia: 19.5% and
abdominal obesity: 76.3%) (Table 6, Supplementary
Fig. 4). For the remaining individual risk factors, South
African men had the highest rates of low HDL (65.7%),
while women from Ghanaian and USA showed the high-
est prevalence for elevated blood sugar.
Drinking and cardiometabolic risk
The results of the relationship between drinking and
CM risk is presented in Table 7, and by individual site in
Supplementary Tables 1, 2, 3, 4 and 5.
Elevated Blood pressure
Overall, heavy drinkers had significantly increased odds
for high BP when compared to non-drinkers (odds ratio
(OR) = 1.59, p = 0.001). Men who were heavy drinkers
had significantly higher odds of elevated BP in compari-
son to men who were non-drinkers (OR = 2.25, p <
0.001). However, this association was not significant
among men who were light drinkers when compared to
men who were non-drinkers (OR = 1.43, p = 0.089).
Table 1 Demographic data, by site for men
Ghana South Africa Jamaica Seychelles United States Overall
N 207 236 249 230 245 1167
Mean Age 34.6 ± 6.7 33.7 ± 5.6** 34.0 ± 5.9** 36.4 ± 5.1 35.6 ± 6.2 34.9 ± 6.0
Weight (Kg) 63.6 ± 9.1** 65.6 ± 13.6** 73.1 ± 15.0** 80.1 ± 16.0** 92.7 ± 24.8 75.4 ± 19.8
Height (cm) 169.0 ± 6.6** 170.9 ± 6.3** 176.0 ± 6.7 173.9 ± 6.2** 176.6 ± 6.6 173.4 ± 7.1
BMI (Kg/m2) 22.2 ± 2.7** 22.4 ± 4.3** 23.6 ± 4.5** 26.5 ± 4.9** 29.7 ± 7.5 25.0 ± 5.8
Waist (cm) 77.2 ± 10.4** 81.0 ± 11.5** 80.3 ± 12.1** 89.4 ± 11.8** 97.2 ± 21.6 85.2 ± 16.0
Hip (cm) 91.7 ± 10.9** 94.6 ± 8.4** 95.1 ± 9.3 ** 102.8 ± 9.6** 109.2 ± 15.9 98.9 ± 12.9
WHR 0.84 ± 0.054** 0.85 ± 0.058** 0.84 ± 0.059** 0.87 ± 0.059* 0.88 ± 0.090 0.86 ± 0.067
Overweight/Obese, (N) % 31 (14.98)** 48 (20.34)** 74 (29.72)** 134 (58.26)** 176 (71.02) 532 (45.7)
Smokers, (N) % 13 (6.28)** 152 (64.41) 106 (42.91)** 86 (37.39)** 175 (71.72) 697 (27.79)
MVPA Duration (min/day) 46.9 ± 24.6** 55.5 ± 34.6** 29.6 ± 23.3 35.9 ± 24.3 33.1 ± 34.7 40.1 ± 30.6
*p < 0.05, and **p < 0.01. Reference is USA
Table 2 Demographic data, by site for women
Ghana South Africa Jamaica Seychelles United States Overall
N 293 268 251 270 257 1339
Mean Age 34.0 ± 6.6 33.1 ± 6.0** 34.7 ± 6.2 35.8 ± 5.6 35.0 ± 6.3 34.5 ± 6.3
Weight (Kg) 63.5 ± 13.1** 82.0 ± 22.3** 78.5 ± 18.6** 72.1 ± 17.3** 91.7 ± 24.4 77.2 ± 21.6
Height (cm) 158.0 ± 5.7** 160.1 ± 6.3** 163.2 ± 6.6 161.4 ± 6.5** 164.0 ± 6.2 161.2 ± 6.6
BMI (Kg/m2) 25.5 ± 5.2** 31.0 ± 8.2** 29.5 ± 6.7** 27.6 ± 6.2** 34.1 ± 8.8 29.6 ± 7.7
Waist (cm) 84.2 ± 12.5** 97.0 ± 16.4** 92.0 ± 13.8** 87.9 ± 12.3** 101.9 ± 19.6 92.3 ± 16.4
Hip (cm) 100.2 ± 13.3** 114.2 ± 15.7* 107.9 ± 11.6 ** 104.4 ± 12.4** 117.1 ± 16.0 108.5 ± 15.2
WHR 0.84 ± 0.070** 0.85 ± 0.076** 0.85 ± 0.066** 0.84 ± 0.057** 0.87 ± 0.090 0.85 ± 0.073
Overweight/Obese, (N) % 141 (48.12)** 209 (77.99)* 181 (72.11)** 165 (61.11)** 219 (85.21) 915 (68.34)
Smokers, (N) % 0 (0.0)** 21 (7.87)** 43 (17.13)** 17 (6.3)** 84 (32.68) 165 (12.33)
MVPA Duration (min/day) 25.9 ± 16.7** 22.0 ± 16.2** 19.5 ± 15.3** 22.9 ± 14.7** 15.1 ± 17.7 21.2 ± 16.6
*p < 0.05, and **p < 0.01. Reference is USA
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Women did not show any significant associations for al-
cohol consumption and high BP.
Light drinkers had 2.05 times the odds of having high
BP compared to non-drinkers (p = 0.022). Heavy
drinkers had 2.93 times the odds of having hypertension,
compared to non-drinkers (p = 0.002); however, this as-
sociation was primarily driven by USA men (OR = 3.5,
p = 0.016). Both light and heavy drinking status among
USA women showed tendencies towards higher odds of
elevated BP, although neither of these associations
showed significance (light drinkers: OR = 2.16, p = 0.061;
heavy drinkers: OR = 2.31, p = 0.072).
Hypertriglyceridemia
Overall, both light and heavy drinking were significantly
associated with an increased odds of hypertriglyc-
eridemia. Light drinking participants had 1.48 times the
odds of having high triglyceride levels compared to non-
drinkers (p = 0.030), while heavy drinkers had 1.73 times
the odds of having hypertriglyceridemia compared to
non-drinkers (p = 0.006). Only Ghanaians had associa-
tions between drinking status and triglyceride levels,
where both light and heavy drinking were significantly
associated with hypertriglyceridemia.
Low HDL
Both light and heavy drinking were significantly associ-
ated with having low HDL. Light drinkers had 0.69 times
the odds of having low HDL compared to non-drinkers
(p = 0.002), while heavy drinking participants had 0.621
times the odds of having low HDL compared to non-
drinkers (p < 0.0005). Overall, men were more likely to
have a significant association between heavy drinking
and low HDL (OR = 0.516, p = 0.002). Similarly light
drinking females were more likely to have healthy HDL
levels (OR = 0.677, p = 0.013).
For the site-specific associations, heavy drinking Gha-
naians were significantly more likely to have low HDL
(OR = 3.51, p = 0.021) (Supplementary Table 1). Among
South Africans, light drinkers had 0.359 times the odds
for having low HDL compared to non-drinkers (p = 0.004)
and heavy drinking participants had 0.314 times the odds
for having low HDL compared to nondrinkers (p <
0.0005) (Supplementary Table 2). These associations
remained significant after stratifying by sex. Light drinking
men had 0.319 times the odds (p = 0.015) and heavy
drinking men had 0.281 the odds of low HDL (p = 0.001)
when compared to non-drinking counterparts. Among
South African women, drinking was associated with low
Table 3 Alcohol consumption data by site for men
Ghana South Africa Jamaica Seychelles United States Overall
N 207 236 249 230 245 1167
Percent Drinkers (N) % 119 (57.49)** 172 (72.88)** 222 (89.16) 206 (89.57) 222 (90.61) 941 (80.63)
# Days Drink/yr 148 ± 138** 145 ± 96** 90 ± 104 84 ± 97* 99 ± 102 108 ± 108
# drinks/day 1.9 ± 1.3** 6.5 ± 5.8** 2.7 ± 1.9* 5.2 ± 3.7** 3.9 ± 3.2 4.1 ± 3.9
# drinks special occasion 2.0 ± 2.2** 7.4 ± 7.1** 4.6 ± 4.6 10.0 ± 5.5** 4.8 ± 4.2 6.0 ± 5.7
# Abstain, (N) % 88 (42.51)** 64 (27.12)** 27 (10.84) 24 (10.43) 23 (9.39) 226 (19.37)
# Light Drinker (1–3), (N) % 101 (48.79) 46 (19.49)** 167 (67.07)* 67 (29.13)** 137 (55.92) 51 (44.39)
# Heavy Drinker (> = 4), (N) % 18 (8.70)** 126 (53.39)** 55 (22.09)** 139 (60.43)** 85 (34.69) 423 (36.25)
*p < 0.05, and **p < 0.01. Reference is USA. Categories for Abstain, Light drinker, and Heavy drinker are defined by the National Institute of Alcohol Abuse and
Alcoholism (NIAAA). Number of Drinks a Day, Number of Drinking Days per year, and Number of Drinks on Special occasions exclude participants that indicated
that they do not drink regularly
Table 4 Alcohol consumption data by site for women
Ghana South Africa Jamaica Seychelles United States Overall
N 293 268 251 270 257 1339
Percent Drinkers (N) % 66 (22.53)** 58 (21.64)** 157 (62.55)** 230 (85.19) 212 (82.49) 723 (54.00)
# Days Drink/yr 82 ± 117** 115 ± 92** 39 ± 68 39 ± 63 49 ± 70 51 ± 77
# drinks/day 1.4 ± 0.83** 5.5 ± 4.4** 2.1 ± 1.4* 3.1 ± 2.1* 2.6 ± 2.3 2.8 ± 2.4
# drinks special occasion 1.1 ± 1.5** 5.6 ± 4.8** 2.6 ± 2.7 4.8 ± 3.2** 3.1 ± 3.1 4.9 ± 0.24
# Abstain (N) % 227 (77.47)** 210 (78.36)** 94 (37.45)** 40 (14.81) 45 (17.51) 616 (46.00)
# Light Drinker (1–2) (N) % 54 (18.43)** 13 (4.85)** 111 (44.22)* 106 (39.26)** 142 (55.25) 426 (31.81)
#Heavy Drinker (> = 3) (N) % 12 (4.10)** 45 (16.79)** 46 (18.33)* 124 (45.93)** 70 (27.24) 297 (22.18)
*p < 0.05, and **p < 0.01. Reference is USA. Categories for Abstain, Light Drinker, and Heavy Drinker are defined by the National Institute of Alcohol Abuse and
Alcoholism (NIAAA). Number of Drinks a Day, Number of Drinking Days per year, and Number of Drinks on Special occasions exclude participants that indicated
that they do not drink regularly
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HDL (light drinkers: OR = 0.287, p = 0.035; heavy drinkers
OR = 0.314, p = 0.004). Among subjects from the USA,
heavy drinking was significantly associated with having a
decreased odds for low HDL (OR = 0.513, p = 0.040).
Waist circumference
The study could not account for significant associations
between levels of alcohol consumption and abdominal
obesity. Site-specific associations showed that among
Ghanaians, light drinking was significantly associated
with having abdominal obesity (OR = 2.15, p = 0.017).
This association was driven by Ghanaian women, among
who light drinking participants had 2.15 times the odds
of having abdominal obesity compared to nondrinkers
(p = 0.015). Similarly, women who were heavy drinkers
from the USA had a strong trend of having abdominal
Table 5 Cardiometabolic statistics and prevalence by site for men
Ghana South Africa Jamaica Seychelles United States Overall
N 207 236 249 230 245 1167
Fasted blood glucose mg/dL 100.9 ± 11.7 85.0 ± 13.8** 95.4 ± 9.1** 107.0 ± 37.3 105.8 ± 34.1 98.8 ± 25.7
Elevated blood glucose (N) % 41 (19.81) 12 (5.08)** 15 (6.02)** 68 (29.57) 61 (24.90) 197 (16.88)
SBP (mmHg) 118.9 ± 13.1** 129.0 ± 17.1** 121.5 ± 12.8* 122.7 ± 14.6** 127.8 ± 14.5 124.1 ± 15.0
DBP (mmHg) 68.5 ± 11.4** 79.6 ± 13.1** 71.2 ± 11.1** 75.0 ± 11.4** 81.0 ± 12.1 75.2 ± 12.7
Elevated blood pressure, (N) % 33 (15.94)** 113 (47.88)** 46 (18.47)** 79 (34.35)* 116 (47.35) 387 (33.16)
Triglycerides (mg/dL) 88.2 ± 45.9 105.2 ± 162.1 71.5 ± 32.8 97.0 ± 77.1 95.8 ± 57.0 93.0 ± 91.88
Elevated triglycerides, (N) % 25 (12.08) 36 (15.25)* 96 (38.55)** 36 (15.65) 38 (15.51) 231 (19.79)
HDL (mg/dL) 44.7 ± 16.4** 54.0 ± 19.8 47.1 ± 12.6** 47.4 ± 13.7** 50.1 ± 14.9 49.0 ± 16.4
Low HDL, (N) % 92 (44.44)** 62 (26.27)* 53 (21.29) 45 (19.57) 74 (30.20) 326 (27.93)
LDL (mg/dL) 92.5 ± 30.3* 80.5 ± 38.3** 94.5 ± 29.6** 112.8 ± 35.0 112.8 ± 34.2 97.6 ± 36.2
Cholesterol (mg/dL) 154.8 ± 35.3** 155.3 ± 40.3** 155.9 ± 32.8** 176.1 ± 35.9 182.0 ± 39.0 165.8 ± 38.9
Ratio cholesterol/HDL (mg/dL) 3.9 ± 12.2** 3.1 ± 1.1 3.5 ± 1.1 4.0 ± 1.2* 3.9 ± 1.2 3.6 ± 1.5
CRP (mg/dL) 3.8 ± 12.7 5.6 ± 11.6 2.2 ± 3.7 2.0 ± 2.2* 4.6 ± 11.6 3.7 ± 9.8
Abdominal obesity, (N) % 3 (1.46) 13 (5.63) 11 (4.42)** 29 (12.66)** 85 (34.98) 141 (12.19)
Elevated CM risk, (N) % 15 (7.25) 21 (8.90) 6 (2.41)* 35 (15.22) 54 (22.04) 131 (11.23)
*p < 0.05, and **p < 0.01. Reference is USA. Cardiometabolic conditions are defined using the ATP III Guidelines [30]
Table 6 Cardiometabolic statistics and prevalence by site for women
Women Ghana South Africa Jamaica Seychelles United States Overall
N 293 268 251 270 257 1339
Fasted blood glucose mg/dL 99.8 ± 12.5 83.1 ± 28.8** 90.9 ± 9.2** 95.3 ± 17.9 100.6 ± 35.4 94.0 ± 23.7
Elevated blood sugar (N) % 53 (18.09) 11 (4.10)** 9 (3.59)** 24 (8.89)* 44 (17.12) 141 (10.53)
SBP (mmHg) 110.4 ± 15.1** 118.1 ± 18.6 115.2 ± 14.7 110.9 ± 12.7** 117.4 ± 16.2 114.3 ± 15.9
DBP (mmHg) 66.1 ± 11.4** 76.3 ± 11.8 72.1 ± 11.4** 71.2 ± 9.9** 79.6 ± 13.2 72.9 ± 12.5
Elevated blood pressure (N) % 31 (10.58)** 192 (28.36) 52 (20.72)** 58 (21.48)** 89 (34.63) 306 (22.85)
Trigs (mg/dL) 77.5 ± 45.0** 76.3 ± 37.1** 74.3 ± 38.4** 64.5 ± 35.6** 96.7 ± 61.6 77.6 ± 43.5
High triglycerides (N) % 17 (5.8)** 11 (4.10)** 18 (7.17)** 12 (4.44)** 50 (19.46) 108 (8.07)
HDL (mg/dL) 47.1 ± 13.2** 46.2 ± 16.5** 46.1 ± 11.8** 47.9 ± 12.2** 51.8 ± 14.8 47.8 ± 14.1
Low HDL (N) % 156 (53.24)** 176 (65.67)** 156 (62.15)** 96 (35.56) 110 (42.80) 694 (51.83)
LDL (mg/dL) 103.4 ± 29.7 98.5 ± 27.8** 106.2 ± 28.4 109.3 ± 33.0 107.4 ± 33.1 104.6 ± 30.5
Cholesterol (mg/dL) 166.0 ± 34.4** 159.9 ± 33.3** 167.2 ± 33.9** 166 ± 34.5** 178.5 ± 38.6 167.3 ± 35.38
Ratio cholesterol/HDL (mg/dL) 3.7 ± 1.1** 3.7 ± 1.0 3.8 ± 0.98** 3.8 ± 1.2** 3.6 ± 0.97 3.7 ± 1.1
CRP (mg/dL) 5.3 ± 13.5 9.5 ± 19.6* 5.4 ± 7.2 3.9 ± 5.7 7.3 ± 9.7 6.3 ± 12.5
Abdominal obesity (N) % 95 (32.53) 179 (67.04) 148 (59.2) 124 (45.93) 196 (76.26) 742 (55.54)
Elevated CM risk (N) % 26 (8.87)** 42 (15.67)* 38 (15.14)* 28 (10.37)* 70 (27.24) 204 (15.24)
*p < 0.05, and **p < 0.01. Reference is USA. Cardiometabolic conditions are defined by using ATP III Guidelines [30]
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obesity, but this was not statistically significant (OR =
2.44, p = 0.090).
Cardiometabolic risk
Overall, we did not find a significant association be-
tween alcohol consumption status and elevated CM
risk (3 out of 5 risk factors). However, among heavy
drinking males, there was a strong trend for ele-
vated CM risk (OR = 1.87, p = 0.065). In addition,
only Ghanaians showed relationships between alcohol
consumption and elevated CM risk. Light drinking
Ghanaians had an increased odds for having elevated
CM risk (OR = 2.15, p = 0.017), while heavy drinking
Ghanaian men were significantly more likely to
present with elevated CM risk (OR = 10.4, p = 0.012).
Similarly, light drinking Ghanaian women were
significantly more likely to present with elevated CM
risk (OR = 2.48, p = 0.046).
Discussion
We evaluated the association between alcohol consump-
tion and elevated CM risk in five African-origin popula-
tions spanning the epidemiologic transition. The study
found that among the groups, heavy alcohol consump-
tion tended to be associated with an increased odds for
presenting with elevated CM risk. It was observed that
within sites, drinking status was associated with the vari-
ous components of CM risk, including elevated BP, high
triglycerides and low HDL. These associations varied
greatly across each of the five sites, suggesting an effect
of environmental factors on CM risk. These relation-
ships also varied when stratified by sex indicating that
sex may modify the association between alcohol con-
sumption and CM risk.
We did, however, find that the association between al-
cohol consumption and increased CM risk is not con-
sistent. For example, Freiberg et al. found that
moderate alcohol consumption was significantly with
a decreased risk for elevated CM risk [22]. This is in
contrast to a recent meta-analysis from the Global Bur-
den of Disease Study group, which suggested that alco-
hol consumption significantly increased CM risk [10].
Each of these studies, regardless of findings, demon-
strated a dose-response effect, in which increased alco-
hol consumption resulted in either the protective or
increased risk for the five CM risk factors [10, 21, 22, 31,
32]. While our study found no significant association be-
tween any amount of alcohol consumption and having
increased CM risk, the data suggest a trend between
heavy alcohol consumption and risk for CM among the
men. This association was however, negated among the
women as well as for the site-specific analyses, except
among Ghanaian light drinkers who had a significant
Table 7 Association of National Institute of Alcohol Abuse and Alcoholism drinking status and CM risk across all study sites
ODDS RATIO 95% CONFIDENCE INTERVALS P-value
Elevated blood glucose
Light drinkers 0.760 0.543↔1.06 0.110
Heavy drinkers 0.890 0.610↔1.30 0.548
Elevated blood pressure
Light drinkers 1.14 0.871↔1.49 0.343
Heavy drinkers 1.59 1.20↔2.10 0.001
High triglycerides
Light drinkers 1.48 1.04↔2.12 0.030
Heavy drinkers 1.73 1.17↔2.55 0.006
Low HDL
Light drinkers 0.690 0.548↔0.868 0.002
Heavy drinkers 0.621 0.480↔0.803 < 0.0005
Abdominal obesity
Light drinkers 0.829 0.626↔1.10 0.193
Heavy drinkers 0.961 0.707↔1.31 0.803
High CM risk
Light drinkers 1.05 0.745↔1.47 0.792
Heavy drinkers 1.11 0.787↔1.64 0.489
Associations adjusted for site, sex, smoking status, physical activity, and age. The reference is non-drinking status as defined by the National Institute of Alcohol
Abuse and Alcoholism (NIAAA) Guidelines [29]
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odds for having elevated CM risk. It is important to note
that the lack of a significant association between heavy
drinking and elevated CM risk in Ghana may be due to
the small number of heavy drinkers, as only eighteen
Ghanaian men and twelve Ghanaian women qualified as
heavy drinkers.
While previous studies have not investigated the asso-
ciation between alcohol consumption and high CM risk
specifically among African-origin populations, several
studies have explored the prevalence of high CM risk in
each of our five cohorts. For example, the prevalence of
high CM risk in Ghana was found to be 5.9% in men
and 24% in women in 2012 [33]. In South Africa, the
prevalence was 10.5% in men and 25% in women in
2011 and 11% of men and 23% of women in Jamaica had
high CM risk in 2008 [18]. In Seychelles, the prevalence
was 24% in men and 32.2% in women in 2008 [27]; and
among US-African Americans, 24% of men and 42% of
women had the metabolic disorder in 2003. With the ex-
ception of Ghanaian men, these previous studies re-
ported higher rates of high CM risk than this
investigation. In some cases, the differences in preva-
lence exceeded 20%, as was the case for the USA and
Seychelles.
However, our data, also, identified similar findings as
previous studies. For example, we similarly identified
higher prevalence of CM risk among Ghanaian women
compared to Ghanaian men. Similarly, we identified a
higher prevalence of low HDL among Ghanaian and
South African women when compared to Ghanaian and
South African men, respectively. Our data and previous
data showed that prevalence of having an elevated CM
risk increased with the site’s developmental index, i.e.
lowest prevalence among Ghanaians and highest preva-
lence among the US cohort. Similar to previous litera-
ture, we confirmed that women had higher rates of
elevated CM risk than men [18–20, 34]. Similarities to
previous research are limited as, to our knowledge, no
other study has investigated the association between al-
cohol intake and CM risk in these populations.
Alcohol consumption has also previously been mea-
sured in each of the five cohorts. For example, previous
studies have found that approximately 80% of Ghanaians
were regular drinkers [34], 56% of men and 26% of
women from South Africa admitted to drinking regularly
[16] and in Jamaica 57% of men and 35% of women re-
ported that they were regular drinkers [16]. In the
Seychelles, approximately 51% of men and 6% of women
were regular drinkers [17]; and about 75.5% of men and
63% of women reported to be drinking regularly in the
USA [16]. These studies are not in line with our study,
and may be partly due to the different classification of
alcohol consumption, as well as differences in the
methods and questions used to obtain self-reported data.
Self-reported data generally introduce variation as the
participants subjectively provide these data as opposed
to objectively measuring alcohol consumption. There-
fore, the methods used to obtain these self-reported data
may introduce variation between studies. Despite these
differences, we did find that more women were more
likely to abstain from alcohol consumption compared to
men in all sites.
One of the primary limitations of this study is that
all alcohol data were self-reported, thus introducing
biases, such as social desirability. Depending on the
country of origin and social tolerance to alcohol
drinking, some participants may under-report their al-
cohol consumption, and such systematic misclassifica-
tion may be related to sex or different population
sub-groups. Furthermore, alcohol habits may change
over time, including low consumption or abstinence;
following disease, itself possibly related to alcohol.
However, this is not likely the case due to the rela-
tively young ages of the study participants. Another
limitation is that alcohol drinking patterns (e.g. binge
vs. regular) and alcohol types (e.g. wine, beer, spirts,
home-brews), which are factors that may alter the im-
pact alcohol intake has on CM risk, were not cap-
tured. The prevalence of heavy drinking was relatively
low in most of the sites, particularly in women, which
minimizes statistical power for association analysis. In
some instances, we were underpowered to detect stat-
istical significance. For example, we were unable to
test the association between heavy drinking status and
risk for elevated blood glucose in Ghanaian women,
as none of the heavy drinking female Ghanaians had
hyperglycemia. Indeed, this site confounding may have
masked some of the associations, although we
attempted to address this by using dummy variables
for site. Finally, it is a major limitation that we were
unable to describe any potential mechanisms for the
association between alcohol intake and prevalence of
CM risk in our international cohort. However, our
study is strengthened by the objective clinical mea-
sures, performed by certified staff, using standardized
procedures and the same make of equipment across
the five sites. Additionally, the biochemical samples
were centrally stored and analyzed at the same
laboratory.
Conclusion
While we were able to detect several statistically signifi-
cant associations between individual CM risk factors and
alcohol consumption, these associations were inconsist-
ent. The associations between alcohol consumption and
elevated CM risk and its components varied markedly
between the 5 cohorts in this study. This is not unex-
pected, given the current widely reported alcohol
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consumption effects. Alcohol intake was indeed, in-
versely related to lower HDL and higher triglycerides in
nearly all sites in our study. While cost-effective strat-
egies to reduce alcohol consumption have been imple-
mented, our data also underscore differences on health
outcomes between countries, and the need to tailor na-
tional programs and policies accordingly. Future studies
should focus on understanding the individual site-
related effects.
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